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Inflammation and wound healing are determinants of disease progression and clinical outcome in atherosclerosis. They 
are emerging as interrelated processes with overlapping molec-
ular mechanisms controlling monocyte infiltration and differ-
entiation into macrophages, whose phenotype determines the 
stability of lesions, by controlling the balance between matrix 
degradation and inflammation versus matrix deposition and 
resolution of inflammation and wound healing.1
Clinical Perspective on p 501
Monocyte/macrophage intravasation is an essential 
step for metabolic disease pathogenesis including athero-
sclerosis. The ability of monocytes to roll and adhere to 
the endothelium in response to chemokines is crucial for 
macrophage accumulation.2 It relies on actin-dependent 
morphological polarization, formation of filopodia and 
Background—Leukocyte migration is critical for the infiltration of monocytes and accumulation of monocyte-derived 
macrophages in inflammation. Considering that Hck and Fgr are instrumental in this process, their impact on atherosclerosis 
and on lesion inflammation and stability was evaluated.
Methods and Results—Hematopoietic Hck/Fgr-deficient, LDLr−/− chimeras, obtained by bone marrow transplantation, had 
smaller but, paradoxically, less stable lesions with reduced macrophage content, overt cap thinning, and necrotic core 
expansion as the most prominent features. Despite a Ly6Chigh-skewed proinflammatory monocyte phenotype, Hck/Fgr 
deficiency led to disrupted adhesion of myeloid cells to and transmigration across endothelial monolayers in vitro and 
atherosclerotic plaques in vivo, as assessed by intravital microscopy, flow cytometry, and histological examination of 
atherosclerotic arteries. Moreover, Hck/Fgr-deficient macrophages showed blunted podosome formation and mesenchymal 
migration capacity. In consequence, transmigrated double-knockout macrophages were seen to accumulate in the fibrous 
cap, potentially promoting its focal erosion, as observed for double-knockout chimeras.
Conclusions—The hematopoietic deficiency of Hck and Fgr led to attenuated atherosclerotic plaque formation by abrogating 
endothelial adhesion and transmigration; paradoxically, it also promoted plaque instability by causing monocyte subset 
imbalance and subendothelial accumulation, raising a note of caution regarding src kinase–targeted intervention in plaque 
inflammation.   (Circulation. 2015;132:490-501. DOI: 10.1161/CIRCULATIONAHA.114.012316.)
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lamellipodia, binding of integrins to endothelial adhe-
sion molecules, cytoskeletal reorganization,3 and signal 
transduction pathways ultimately leading to the concerted 
loosening of adherent junctions on endothelial cells4 and 
monocyte transmigration across endothelial, basement 
membrane, and fibrous cap barriers, before their homing 
in expanding lesions and differentiation into pro- or antifi-
brotic macrophages.
Hck and Fgr are 2 Src tyrosine kinases that display restricted 
coexpression in myeloid cells where they regulate β2-integrin 
binding to endothelial intercellular adhesion molecule-1 to 
facilitate cell adhesion and migration on P-selectin glycopro-
tein ligand-1 (PSGL-1) and CD44 interaction with endothelial 
E-selectin and P-selectin.5,6 In addition, Hck and Fgr are a con-
vergence point of signaling pathways initiated by a wide range 
of cell receptors implicated in the pathogenesis of atheroscle-
rosis, including integrins, immune and growth factors, Fc-γ 
receptors (Fcγ) and chemokine receptors. These kinases exert 
their functions by the activation of several effectors including 
Rac/CDC42, spleen tyrosine kinase (Syk), and protein tyrosine 
kinase (PyK),7 which are implicated in the accumulation and 
trapping of macrophages in atherosclerosis.8–11 As expected 
from signaling molecules targeted by multiple receptors, Hck 
and Fgr mediate a broad spectrum of processes, ranging from 
cell proliferation, survival, and differentiation, to cytokine 
secretion, cytoskeleton dynamics, integrin-dependent cell 
adhesion, to the endothelium and migration.7,12–15
In light of these data, we hypothesized that Hck/Fgr defi-
ciency would lead to reduced accumulation of macrophages 
in atherosclerosis onset and progression, a consequence of 
reduced diapedesis and migration. Our data imply that Hck 
and Fgr not only are progressively overexpressed in athero-
sclerosis, but they also control critical molecular processes in 
monocyte influx, blood monocyte subset balance, macrophage 
accumulation, and the maintenance of atherosclerotic lesion 
stability.
Materials and Methods
Animal Experiments
Bone marrow transplantation, perivascular collar placement, and 
intravital microscopy experiments were approved by the local regula-
tory authorities of Leiden and Maastricht, and performed in accor-
dance with Dutch, French, and German government guidelines as 
described in the online-only Data Supplement Methods.
Cholesterol and Triglyceride Levels
Blood samples were taken by tail bleeding 1 day before and 5 weeks 
after the introduction of Western type diet (WTD) and at euthani-
zation. Total plasma cholesterol, triglyceride, and phospholipid con-
tents were measured by an enzymatic-colorimetric assay (Roche 
Diagnostics, Almere, The Netherlands).
Plasma Cytokine Levels
The Luminex 100 Bio-Plex cytokine assay (Bio-Rad Laboratories, 
Inc; Hercules, CA) was used to determine plasma levels of: inter-
leukin (IL)-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL12(P40), 
IL-12(P70), IL-17, eotaxin, keratinocyte chemoattractant, monocyte 
chemoattractant protein-1, monocyte inflammatory protein-1α, and 
tumor necrosis factor-α (TNF-α). Statistical analysis was performed 
for the cytokines that reached the limit of detection (IL-1β, IL-12, 
eotaxin, monocyte chemoattractant protein-1, and IL-1α).
Blood Cell Analysis and Flow Cytometry
Blood, bone marrow, and peritoneal cells were harvested at euthaniza-
tion, and single-cell suspensions were prepared. Lysis of erythrocytes 
was performed in ice-cold NH4Cl (8.4 g/L), NaHCO3 (1 g/L), and 
ethylenediaminetetraacetic acid (37 mg/L) during 3 minutes. Single-
cell suspensions were stained with fluorescent label–conjugated anti-
bodies for different markers and analyzed by fluorescence-activated 
cell sorting as detailed in the online-only Data Supplement Methods. 
Whole-blood samples were analyzed on a Sysmex blood cell analyzer 
(XT-2000i, Sysmex Europe GmbH, Norderstedt, Germany).
Cell Culture
Bone marrow–derived macrophages (BMDM) and peritoneal mac-
rophages, vascular smooth muscle cells (SMC), human aortic endo-
thelial cells, and Jurkat lymphocytes were cultured as detailed in the 
online-only Data Supplement Methods.
Thioglycolate-Induced Peritonitis
Cells were collected for analysis by fluorescence-activated cell sort-
ing and microscopic quantification by Giemsa staining 1, 3, or 5 days 
(as indicated) after the induction of peritonitis with a sterile solution 
of dehydrated Brewer complete thioglycolate broth (1 mL, 2%–3% 
wt/vol, Difco Laboratories, West Molesy, UK).
Phagocytosis, Apoptosis, and Proliferation Assays
Proliferation and apoptosis assays, phagocytosis of apoptotic cells 
and zymosan particles, and cholesterol uptake experiments are 
detailed in the online-only Data Supplement Methods.
Macrophage Adhesion and Transmigration Across 
the Endothelium
Human aortic endothelial cells (PromoCell) were grown and prein-
cubated with TNF-α (10 ng/mL) for at least 4 hours. Hck and Fgr 
mutant BMDM or wild-type (WT) controls were suspended at 5×105 
cells/mL in 1× Hanks buffer, 20 mmol/L 4-(2-hydroxyethyl)-1-piper-
azineethanesulfonic acid, 0.5% human serum albumin (Baxter), and 
1 mmol/L calcium and magnesium after stimulation with interferon-γ 
(IFN-γ; 100 U/mL Peprotech) during 16 hours. For the assessment 
of cell adhesion, macrophages were perfused over inflamed human 
aortic endothelial cell monolayers during 2 minutes at 0.1 mL/min 
and cells counted in 6 high-power field (100× magnification) pic-
tures. Transmigration was recorded at a flow rate of 0.05 mL/min for 
30 minutes in 15-second intervals by using a differential interference 
contrast microscope.
Macrophage Morphology, Migration, Podosome 
Rosette Formation, and Matrix Degradation
Assessment of macrophage morphology and 2- and 3-dimensional 
migration are detailed in the Methods in the online-only Data 
Supplement.
Gelatin Zymography and β-Hexosaminidase 
Release
Zymography experiments were performed as previously described.13 
In brief, BMDM (1×106 cells/well) were seeded overnight into 6-well 
fibronectin-coated plates. Conditioned cell culture medium and cell 
lysate were subjected to 10% (wt/vol) sodium dodecyl sulfate, 0.1 
mg/mL gelatin gel electrophoresis. For β-hexosaminidase release, 
BMDM were seeded overnight into 6-well plates, the assay was per-
formed on cell extracts obtained in 1% Triton X-100 and supernatants 
as previously described.15
Classical and Alternative Macrophage Polarization
BMDM (5×105 cells/well) were seeded in 24-well plates and allowed 
to adhere overnight before immune polarization was induced by 
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24-hour incubation with 100 U/mL IFN-γ (Peprotech) or 20 ng/mL 
IL-4 (Peprotech). RNA isolation, cDNA synthesis, and real-time 
polymerase chain reaction were performed as detailed in the online-
only Data Supplement Methods.
SMC Collagen Synthesis and Proliferation
Cell proliferation, collagen, and noncollagenous protein extracellular 
deposition were assessed in vascular SMC layers by enzyme-linked 
immunosorbent assay (Roche, BrdU colorimetric kit) and a quantita-
tive collagen and protein microassay kit (Chondrex, Inc, Redmond, 
WA), respectively, according to the manufacturers’ instructions.
Tissue Harvesting, Immunohistochemistry, and 
Plaque Morphometry
Mice were anesthetized, euthanized, and perfused before the collec-
tion of hearts, aortas, common carotid arteries, peritoneal ascites, 
and other organs as described in the online-only Data Supplement 
Methods, which also contains a detailed description of cell and tissue 
staining and visualization procedures.
Analysis of Microarray Data
For microarray analysis, total RNA was extracted by using the guani-
dine thiocyanate/CsCl gradient method17 and a NucleoSpin RNA II kit 
(Macherey Nagel, Duren, Germany), from early (n=13) and advanced 
stable (n=16) lesions obtained after autopsy (Department of Pathology, 
University Hospital Maastricht, Maastricht, the Netherlands) or 
advanced stable (n=21) and advanced unstable (n=23) lesions 
obtained on surgery (Department of Surgery, Maasland Hospital 
Sittard, Sittard, the Netherlands). RNA concentration and quality and 
lesion phenotype were determined as detailed in the online-only Data 
Supplement Methods. All human work was approved by the Ethics 
Committee of the University Hospital Maastricht. Written informed 
consent for participation in the study was obtained from all individu-
als. Samples from autopsy were individually hybridized to HGU133 
2.0 Plus arrays (Affymetrix, Santa Clara, CA), and samples from sur-
gery were individually hybridized to Illumina Human Sentrix-8 V2.0 
BeadChip (Illumina Inc, San Diego, CA).
Microarray expression data of macrophage immune polarization 
were obtained at the Gene Expression Omnibus Web site (www.ncbi.
nlm.nih.gov/geo) under accession number GSE18686.18 Data normaliza-
tion and summarization along with statistical, cluster, and Gene Ontology 
analysis are described in the online-only Data Supplement Methods.
Statistical Analysis of Experimental Data
Analyses were done using MatLab’s Statistics ToolBox (Ver7.9) or 
INSTAT (Graphpad Software, Inc). Two-group comparisons were 
analyzed by the Welch Student t test to account for unequal variances 
(except for higher-powered data sets [n>8] with equivalent variance, 
where we opted for an unpaired t test). Two-sided P values of <0.05 
were considered significant and denoted with 1, 2, or 3 asterisks when 
lower than 0.05, 0.01, or 0.001, respectively. Comparisons that did 
not reach significance were not highlighted by an asterisk.
Figure data are presented as mean±standard error of the mean 
(unless otherwise stated), whereas data in Results are given as relative 
change in comparison with the WT control. Regression lines were 
compared by analysis of covariance, using the independent variable 
plaque area as covariate and macrophage content or necrotic core size 
as outcome in a 2-group analysis of covariance. Linear regression 
slopes were plotted with 95% confidence intervals. Multiple com-
parison analyses were analyzed by 1-way analysis of variance with 
Bonferroni correction at a significance threshold of 0.05.
Results
Hematopoietic Deficiency in Hck and Fgr Reduces 
Atherogenesis
A first indication of the participation of the src kinases Hck 
and Fgr in atherosclerotic lesion progression was provided by 
their upregulation in advanced human atherosclerotic lesions 
in comparison with early ones (GSE28829; Figure IA in the 
online-only Data Supplement), whereas the expression of 
both kinases was also significantly increased in human ath-
erosclerotic vulnerable lesions in comparison with stable ones 
(Figure IB in the online-only Data Supplement), linking them 
to lesion progression.
To establish active involvement of Hck and Fgr in athero-
sclerosis, we generated atherosclerosis-prone chimeric mice 
by reconstitution of lethally irradiated LDLr−/− recipient ani-
mals with Hck−/−Fgr−/− double-knockout (dKO) or WT bone 
marrow cells. Hck/Fgr deletion did not lead to any alteration 
in total body weight along the experiment nor did it affect 
plasma total cholesterol levels before (199.4 mg/dL versus 
150.8 mg/dL for WT controls) and after (1616.1 mg/dL versus 
1488.9 mg/dL, for WT controls) WTD introduction. Plasma 
levels of proinflammatory cytokines such as IL-1β, IL-12, 
eotaxin, monocyte chemoattractant protein-1, and IL−1α, as 
measured at euthanization, were not influenced by Hck/Fgr 
deficiency (Figure IC in the online-only Data Supplement).
WTD-fed chimeric mice transplanted with Hck/Fgr dKO 
bone marrow exhibited 30% (P≤0.05) reduction in intermedi-
ate atherosclerotic lesion size (Figure 1A), whereas, at later 
stages of plaque progression, it led to 40% smaller plaques 
(P≤0.01; Figure 1B and 1C). Unexpectedly, despite their 
reduced size, plaques from Hck/Fgr dKO chimeras exhibited a 
more vulnerable plaque phenotype, characterized by necrotic 
core expansion (+68%; P≤0.01; Figure 1D) and significant 
reductions in collagen and SMC (–75% and –82%, respec-
tively, both P≤0.001; Figure 1E and 1F ) and fibrous cap 
thickness (–53%, P≤0.001; Figure 1G and 1H). The apoptotic 
rate in early lesions, as measured by caspase-3 staining, did 
not differ between dKO versus WT chimeras (Figure 1I). The 
diminished plaque fibrosis was coupled with 34% (P≤0.001; 
Figure 1J and 1K) and 61% (P≤0.05; Figure 1L and 1M) 
reductions in intimal macrophage and adventitial neutrophil 
contents, respectively. Because plaque cell proliferation, 
assessed by Ki67 staining, was unchanged (Figure 1N), it is 
unlikely that the reduced plaque macrophage content results 
from Hck/Fgr deficiency–associated effects on plaque macro-
phage expansion. Statistical regression analysis revealed that, 
although necrotic core size and plaque macrophage content 
were both associated with plaque size (P≤0.001 for both), nei-
ther of the 2 did so in a genotype-dependent manner, indicating 
that the changes in plaque macrophage content and necrotic 
core size reflected a delayed plaque progression (Figure ID 
and IE in the online-only Data Supplement). The reduced 
presence of (F4/80+) plaque macrophages in dKO versus WT 
chimeras was confirmed by flow cytometry analysis of aorta 
(–42%, P≤0.001), whereas vascular CD3+-T lymphocyte con-
tent was unchanged (Figure 2A and 2B). This aligns well with 
the observation that Hck and Fgr showed highest expression 
in myeloid cells at mRNA (Figure 2C) and protein level, as 
well (Figure 2D).
To address whether the diminution of plaque macrophage 
and neutrophil numbers was caused by a reduced availability 
of myeloid subsets in dKO chimeras, we studied the impact 
of Hck/Fgr deficiency on myeloid versus nonmyeloid subset 
patterns in blood, spleen, and bone marrow. The absolute and 
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relative levels of circulatory, bone marrow, and spleen white 
blood cells, T (cytotoxic, helper, and Tregs) and B lympho-
cytes, and spleen dendritic cells (resident and plasmacytoid), 
as well, were not disturbed in WTD-fed dKO chimeric mice 
(data not shown) in comparison with WT controls. Similarly, 
equivalent myeloid cell composition (Figure IIA in the online-
only Data Supplement) and monocyte subset levels (Figure 
IIB in the online-only Data Supplement) were observed in 
bone marrow. Expression of Ly6C was not influenced by 
lack of Hck/Fgr in Ly6Clow and Ly6Chigh blood monocyte sub-
sets. This suggests that the increased Ly6C is not attributable 
to the deficiency of Fgr, which was seen to bind Ly6C and 
activate LFA-119 (Figure IIC and IIE in the online-only Data 
Supplement). Similarly, absolute or relative levels of circu-
latory granulocytes and monocytes were unchanged (Figure 
IIF through III in the online-only Data Supplement). Relative 
Ly6Chigh monocyte abundance (+47%, P≤0.01), however, 
was significantly increased (Figure IIJ in the online-only 
Data Supplement), which generally is thought to be associ-
ated with increased invasion into atherosclerotic lesions. 
Nevertheless, significantly fewer leukocytes (Figure 2E) and, 
in particular, fewer monocytes/macrophages (Figure 2F and 
2G) were recruited to the peritoneal cavity of dKO chimeras 
in a model of thioglycolate-induced peritonitis. The expres-
sion of monocyte chemotaxis mediating chemokine receptors 
(CCR2, CCR5, CXCR1-3, and CX3CR1) by sorted Ly6Chigh 
bone marrow monocytes was unchanged (Figure IF in the 
online-only Data Supplement); likewise, dKO macrophages 
did not display altered expression of chemokines CCL2 and 
CCL5 (Figure IG in the online-only Data Supplement). This 
suggests that the reduced macrophage invasion into inflamed 
peritoneum or plaque is not attributable to aberrant chemo-
taxis. No differences in the activation of macrophages were 
observed, as assessed by the expression of CD86, CD40, and 
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Figure 1. Reduced lesion size and altered lesion composition in Hck/Fgr dKO chimeras. Hck/Fgr deficiency led to reduced formation of 
intermediate (–29%, n=8, 10 sections analyzed per unit; A) and advanced lesions (–37%, n=13, 10 sections per unit; B) in aortic roots 
of Western type diet–fed LDLr–/– mice. C, Representative Movat-stained advanced plaque sections. Advanced lesions from Hck/Fgr 
dKO chimeras displayed features of plaque vulnerability characterized by bigger necrotic cores (+68%; D), reduced collagen (–82%; 
E), reduced SMC (–75%) contents (F), and thinner fibrous caps (–53%; G; n=13, 6 sections per experimental unit). H, Representative 
pictures corresponding to D through G denoting lumen size (L), necrotic core (NC) expansion, fibrous cap (FC) thinning, and diminished 
collagen area (Picrosirius Red staining in dKO chimeras). I, Lesion caspase 3+ cell content was unchanged in Hck/Fgr deficiency. Intimal 
macrophages (J and K) and adventitial neutrophils (L and M), were reduced by 34% and 61%, respectively, in advanced lesions. K and 
M display representative slides of macrophage and neutrophil stainings, respectively. Lesions of dKO mice showed similar Ki67+ cell 
content, reflecting unchanged proliferation (N). WT, open circles; dKO, filled circles; *P≤0.05, **P≤0.01, ***P≤0.001. dKO indicates double-
knockout; SMC, smooth muscle cells; and WT, wild type.
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major histocompatibility complex II (Figure 2H), indicating 
that Hck/Fgr deficiency did not perturb the activation potential 
of macrophages, a result that could be relevant for atheroscle-
rotic lesion macrophages.
Lack of Hck/Fgr Leads to Reduced Leukocyte 
Adhesion to the Endothelium
Echoing the reduced accumulation of dKO macrophages in 
peritonitis and atherosclerotic lesions, we found that adop-
tively transferred fluorescently labeled dKO BMDM dis-
played profoundly reduced adhesion (–67%, P≤0.001) and 
almost ablated transmigration (–88%; P≤0.001) to preexist-
ing collar-induced carotid artery lesions induced in WTD-fed 
LDLr–/– mice (Figure 3A through 3C). Next, we performed 
intravital microscopy analysis at the carotid artery bifur-
cation of WTD-fed WT versus dKO chimeras after in situ 
labeling of circulating leukocytes (Rhodamine G or Rho), 
CD11b+ monocytes, CD11b+ Ly6Chigh monocytes, and Ly6G+ 
neutrophils. Concordant with the aforementioned adoptive 
transfer studies, plaque neutrophil and monocyte adhesion 
were sharply reduced (P≤0.001 for all; Figure 3D and 3E), 
at which the effects on CD11b+ Ly6Chigh monocytes seemed 
to be most pronounced. Extending this finding, we sought to 
track the dynamics and more, in particular, the plaque-homing 
capacity of proinflammatory LyC6hi monocytes in WT versus 
Hck/Fgr-deficient mice. Hereto, we used the Ly6Chigh mono-
cyte-specific latex labeling procedure described by Tacke 
et al20 and observed reduced amounts of latex bead–laden 
Ly6Chigh cell–derived macrophages in plaque 24 hours after 
bead labeling as witnessed in flow cytometry and fluorescent 
microscopy analysis (Figure 3F through 3H).
To be able to dissect the individual steps in monocyte 
recruitment to the plaque, we performed flow experiments. 
dKO BMDM perfused through a monolayer of inflamed endo-
thelium in vitro displayed reduced adhesion (–52%; P<0.05; 
Figure 4A and 4B). However, the percentage of adherent cells 
able to transmigrate across the endothelium in vitro was not 
influenced by Hck/Fgr deficiency (Figure 4C), implying that 
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Figure 2. A and B, Flow cytometry analysis of aorta-associated leukocytes in Hck/Fgr dKO vs WT bone marrow–transplanted LDLr−/− 
mice. Hck/Fgr deficiency was associated with a reduced accumulation of F4/80+ macrophages (A) but had no effect on CD3+ lymphocyte 
contents (B) of aortas of WTD-fed LDLr−/− mice. WT, open circles; dKO, filled circles; ***P≤0.001 (n=9). C and D, Expression analysis 
established myeloid cell–specific expression of Hck and Fgr. C, Hck (top) and fgr (bottom) mRNA expression by monocytes (total, 
Ly6Chigh, and Ly6Clow), cDC, neutrophils B cells and T cells isolated by FACS from total spleen of WT and dKO chimeras; expression 
values are expressed relative to that of 18S (mean±SD; n=4). D, Specific expression of Fgr (bottom) and Hck (top) by monocytes and 
macrophages, but not B cells and dendritic cells (Fgr), was confirmed at protein level by Western blot analysis for Hck (59/61 kDa) and 
Fgr (55 kDa). Arrows indicate the position of 70- and 55-kDa calibration markers. β-Actin served as loading control. E through H, Reduced 
thioglycolate induced peritonitis in Hck/Fgr-deficient mice. E, The absolute levels of inflammatory cells recruited to the peritoneal cavity 
was reduced in dKO chimeras 24, 72, and 120 hours after intraperitoneal injection of thioglycolate. F, Absolute monocyte/macrophage 
counts in peritoneal ascites were reduced by 48.5% 120 hours after the induction of peritonitis in dKO chimeras. G, Relative monocyte/
macrophage numbers in the peritoneal cavity were unchanged. H, The expression of activation markers was not perturbed by the lack 
of Hck/Fgr (n=6, duplicated samples per experimental unit). WT, open circles; dKO, filled circles; *P≤0.05, ***P≤0.001. cDC indicates 
conventional dendritic cell; dKO, double-knockout; FACS, fluorescence-activated cell sorting; SD, standard deviation; WT, wild type; and 
WTD, Western type diet.
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the inhibited transendothelial macrophage migration mainly 
reflects the previous impairment of the adhesion mechanism.
This intriguing observation led us to investigate the (trans)
migration process in closer detail. In vitro, dKO BMDM dis-
played almost ablated wound invasion in a wound healing 
assay (–94%, P≤0.001; Figure 4D), despite that proliferation 
rates under baseline and lipopolysaccharide (LPS)-stimulated 
conditions (Figure IIIA in the online-only Data Supplement) 
and seeded cell densities were similar in both genotypes, 
indicating impaired 2-dimensional migration. In addition, 
dKO peritoneal macrophages presented altered morphology 
in vitro characterized by lack of elongation (–56%, P≤0.001) 
and morphological polarization (P≤0.001), whereas the cells 
were also featuring sharply reduced filopodium and lamellipo-
dium formation (Figure 4E through 4I), which is suggestive of 
dysfunctional actin network polymerization.
Taken together, these results indicate impaired adhesion 
and 2-dimensional crawling on the endothelium previous to 
diapedesis, as contributing factors to the reduced macrophage 
accumulation observed in atherosclerotic dKO chimeras.
Hck/Fgr-Deficient Macrophages Display Reduced 
3-Dimensional Migration
We next assessed the 3-dimensional migration capacity of 
dKO macrophages, taking into account that, in particular, at 
later stages of lesion progression, extravasated cells must pass 
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injection showed a reduced presence of bead-laden macrophages in plaques of dKO chimeras (F, Central panels represent overview, I 
and II are high-power views detailing for WT mice, whereas III and IV are high-power views of dKO mice; n=9). Quantitative analysis of 
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through collagen and SMC-rich fibrous caps. Macrophages 
use mesenchymal and amoeboid migration mechanisms 
to perform 3-dimensional infiltration21 either by protease-
dependent degradation of dense extracellular matrices or by 
squeezing and deforming their cell body into extracellular 
matrix pores, respectively. In vitro, dKO BMDM displayed 
unimpeded amoeboid migration across type I fibrillar collagen 
(Figure 5A), which contrasted with their markedly inhibited 
mesenchymal migration through dense Matrigel (Figure 5B). 
Furthermore, the addition of a cocktail of protease inhibitors 
inhibited the mesenchymal migration through Matrigel in WT 
BMDM to levels observed in untreated mutant cells. However, 
it failed to impact the migration capacity of mutant BMDM 
(Figure 5B). This suggests that Hck/Fgr deficiency–associ-
ated ablation of mesenchymal migration implicates protease 
activity. Next, we examined whether dKO BMDM display 
abnormal secretion of proteases. The release of the lysosomal 
hydrolase β-hexosaminidase (Figure 5C), and of metallo-
proteinases 2 and 9, as well, was not affected (Figure 5D) 
however, excluding vesicular secretion defects to have under-
lain the observed impairment of macrophage migration.21
The mesenchymal migration of macrophages requires cell 
adhesion and extracellular matrix–degrading structures called 
podosomes.22–24 As we already have shown, macrophage 
podosome stability and function are regulated by Hck in mac-
rophages.13,16 BMDM from WT mice formed large podosome 
rosettes; dKO cells, in contrast, formed fewer and smaller 
podosome rosettes (Figure 5E and 5F). As a consequence, 
focal extracellular matrix degradation capacity of dKO mac-
rophages as assessed by fluorescein isothiocyanate gelatin 
degradation, was significantly decreased in comparison with 
their WT counterpart (Figure 5G and 5H).
Taken together, these results indicate that Hck/Fgr gene 
deletion causes reduced mesenchymal migration by impairing 
the formation of podosome rosettes leading to diminished peri-
cellular degradation of the extracellular matrix. This potentially 
has major implications for the invasive capacity of extrava-
sated plaque macrophages. Therefore, we have histologically 
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[HPMF] quantifications per sample). C, Representative differential interference contrast microscopy HPMF pictures of BMDM adherent to 
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reinspected the plaque for the presence and location of latex 
bead–labeled cells in the monocytes/macrophages tracking 
study described in Figure 3. In keeping with the impaired 
mesenchymal migration capacity in vitro, we observed that 
significantly less latex+ macrophages had migrated beyond the 
basal membrane into the plaque atheroma (–58%, P<0.001; 
Figure 5I). Moreover, the average invasion depth of latex+ mac-
rophages that had invaded into the plaque at 24 hours after label-
ing was sharply reduced as well (–77%; P≤0.01; Figure 5J).
Hck/Fgr-Deficient Macrophages Display Impaired 
Efferocytosis and an Antifibrotic Phenotype
The subendothelial accumulation of macrophages could 
have contributed to the more vulnerable phenotype of dKO 
chimeras versus their WT counterparts, as hallmarked by 
reduced fibrosis and cap thinning. Because features of plaque 
vulnerability are often associated with disbalanced extracel-
lular matrix homeostasis, owing to the proinflammatory, col-
lagen synthesis inhibitory, and erosive milieu presented by 
plaque macrophages, in particular, if polarized toward a clas-
sically activated phenotype.1 Moreover Ly6Chigh monocytosis, 
as observed in dKO chimeras (Figure IIJ in the online-only 
Data Supplement), by itself has already been linked to prefer-
ential polarization toward classically activated macrophages.25
Therefore, we investigated whether Hck/Fgr deficiency has 
impacted macrophage phenotype. We first assessed whether 
macrophage polarization itself influences Hck/Fgr expression 
by transcriptome analysis of differentially expressed genes 
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from human macrophages stimulated with TNF-α, IL-4, IL-17, 
LPS, IFN-γ, or LPS+IFN-γ (GSE1868618). Hck and Fgr are 
included in separate gene networks, as revealed by K-means 
cluster analysis (C-IV and C-III, respectively; Figure 6A). 
Principal component analysis indicated that C-III and C-IV 
contained genes with upregulated expression in response to 
alternative (IL-4) and classic (LPS, IFN-γ, or LPS+IFN-γ) 
stimulants, respectively (Figure 6B). Consistently, Hck and 
Fgr were more than 2-fold upregulated in response to IFN-γ 
and IL-4, respectively (Figure 6C), suggesting their divergent 
participation in classic and alternatively activated macro-
phage molecular networks, respectively. This was confirmed 
at the protein level by Western blotting on naïve and primed 
BMDM from WT and dKO mice, showing a tendency toward 
increased Hck expression by classically activated macro-
phages and increased Fgr by alternatively activated macro-
phage (Figure 6D and 6E). Although conclusive evidence is 
lacking, classically activated macrophages are believed to 
represent the dominant phenotype in plaque. This therefore 
implies a major role for Hck in plaque macrophage function, 
as also suggested by the upregulation of Hck in advanced rup-
ture-prone human atherosclerotic lesions (Figure IA and IB in 
the online-only Data Supplement)
However, the analysis of polarization marker gene expres-
sion failed to demonstrate consistent Hck/Fgr deficiency–asso-
ciated changes in macrophage phenotype. Baseline mRNA 
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expression of established classically activated macrophage 
markers by nonstimulated BMDM such as inducible nitric 
oxide synthase, IL-12, or TNF-α was essentially unchanged, 
as was that of the alternatively activated macrophage markers 
arginase-1 and the mannose receptor (Figure 6F). Likewise, 
polarization marker gene expression by LPS+IFN-γ or IL-4–
primed WT and dKO BMDM were largely similar (Figure IIIB 
and IIIC in the online-only Data Supplement, respectively). 
At the protein level, dKO and WT BMDM showed equiva-
lent IL-12 secretion, whereas TNF-α production was slightly 
increased (Figure IIID in the online-only Data Supplement) 
and that of nitric oxide was significantly reduced (Figure 
IIIE in the online-only Data Supplement). Concordant with 
these data, mRNA expression analysis on isolated aorta did 
not reveal major changes in macrophage polarization marker 
expression pattern, apart from a slight increase in CD206 
expression (Figure 6G), whereas inducible nitric oxide syn-
thase+ and arg-1+ macrophage content in intermediate lesions 
did not point to a shift toward classical macrophage activation 
in dKO versus WT chimeras either (Figure 6H and 6I).
Because the complexity of macrophage adaptive responses 
in vivo cannot be completely captured by the rigid dichotomy 
of the macrophage polarization model in vitro, we focused on 
Src kinase–associated differences in macrophage functions that 
could underlie dKO-associated plaque destabilization. First, we 
assessed whether Hck/Fgr deficiency impacts macrophage cell 
death or their ability to ingest particles, opsonized particles, and 
cholesterol accumulation, functions that are potentially con-
trolled by src kinases and are relevant to plaque stability. Hck/
Fgr-deficient BMDM exposed normal apoptotic susceptibility 
(Figure IVA in the online-only Data Supplement), phagocytosis 
of fluorescent latex beads or opsonized particles (Figure IVB and 
IVC in the online-only Data Supplement), and uptake of modi-
fied cholesterol, in vitro, as assessed by high-performance thin 
layer chromatography or fluorescent microscopy (Figure IVD 
and IVE in the online-only Data Supplement). Efferocytosis, 
defined as the macrophage capacity to process apoptotic cells, 
however, was considerably reduced in dKO BMDM (Figure IVF 
in the online-only Data Supplement), which could at least in part 
explain the necrotic core expansion observed in dKO chimeras.
Interestingly, incubation of vascular SMC with condi-
tioned medium from nonstimulated dKO BMDM did not 
influence their proliferation (Figure VA in the online-only 
Data Supplement), but reduced their deposition of extracel-
lular collagen and noncollagenous proteins akin to condi-
tioned medium from LPS-primed WT macrophages and 
starvation medium (Figure VB and VC in the online-only 
Data Supplement). Apparently, Hck/Fgr deficiency favors a 
macrophage antifibrotic differentiation phenotype, and we 
propose that the impact of this effect will even be amplified by 
the reduced mesenchymal migration into the plaque of dKO 
macrophages, conducive to increased focal accumulation of 
antifibrotic macrophages in close proximity to the fibrous cap.
Discussion
Here, we present conclusive evidence that Hck/Fgr deficiency 
leads to reduced atherosclerotic lesion burden with concomi-
tant reductions in macrophage accumulation and, paradoxi-
cally, lesion stability. As we show, the former is attributable 
to impaired adhesion of macrophages to the endothelium, 
whereas the latter is likely attributable to blunted mesenchy-
mal migration into the plaque atheroma, resulting in the reten-
tion of lytic macrophages in the plaque’s fibrous cap.
As a first hallmark of Hck/Fgr deficiency, atherosclerotic 
lesions displayed reduced amounts of macrophages despite 
the marked skewing of monocyte differentiation toward a 
Ly6Chigh phenotype, a subset known for its hypermigratory 
and proinflammatory profile and selective accumulation in 
atherosclerosis.20,25
With the use of intra- and extravital microscopy analy-
sis of fluorescent dye, antibody and latex bead–labeled leu-
kocyte subsets, we were able to firmly establish Hck/Fgr 
deficiency–induced impairment of monocyte and neutrophil 
adhesion to and diapedesis into plaque, while their chemotac-
tic profile remained unaffected. This finding was confirmed 
by post hoc immunohistochemical analysis of plaque for 
the presence of latex bead–laden macrophages. The reduced 
presence of (Ly6Chi) monocyte–derived macrophages is espe-
cially remarkable given the relative abundance of circulating 
Ly6Chigh monocytes in dKO chimeras. This subset is thought 
to be associated with higher Ly6Chigh monocyte infiltration20,25 
and reduced accumulation of profibrotic and anti-inflamma-
tory macrophages.26 It should be noted, however, that the 
Ly6Clow subset has been shown to contribute to plaque inflam-
mation at later stages of disease development and has repeat-
edly been linked to plaque vulnerability and fibrosis.27–29
In addition, Hck/Fgr-deficient macrophages featured an 
impaired morphological polarization and disrupted 2-dimen-
sional migration. dKO macrophages were unable to form 
filopodia and lamellipodia, which is critical for those cells 
to adhere and establish leading and trailing poles that direct 
their mobilization toward higher concentrations of chemoat-
tractants.30 Taken together, these results imply that Hck/Fgr 
deficiency results in reduced adhesion and directional crawl-
ing on the endothelium and, therefore, in impaired extravasa-
tion of circulating monocytes into the atherosclerotic lesion. 
The 3-dimensional mesenchymal migration of macrophages 
depends on the formation of podosome rosettes, which release 
proteolytic enzymes to perform pericellular degradation of the 
extracellular matrix.21 In vitro, dKO macrophages exhibited 
an attenuated focal degradation of extracellular matrix, dis-
rupted formation of podosome rosettes, and accordingly dis-
rupted mesenchymal migration. Extrapolating these findings 
to atherosclerosis, Hck/Fgr deficiency has impacted both the 
adhesion of monocytes to the plaque and their mesenchymal 
migration across the lesional fibrous cap, as well, contributing 
to the striking reduction in plaque macrophage content and to 
subendothelial accumulation of invaded macrophages.
A second striking hallmark of Hck/Fgr deficiency in ath-
erosclerosis was the paradoxical induction of necrotic core 
expansion and lesion vulnerability, with reduced fibrosis, 
SMC accumulation, and collagen deposition. This pheno-
type is remarkably similar to that observed in ear excision 
wounds treated with Src tyrosine kinase inhibitors,31 alluding 
to a positive role of Hck/Fgr in macrophage profibrotic func-
tions. Compatible with the latter, conditioned medium from 
dKO macrophages was seen to reduce collagen production by 
vascular SMC. The impact of this plaque-destabilizing effect 
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will be considerably augmented by the increased retention of 
extravasated, migration-defective dKO monocytes in suben-
dothelial tissue close to the fibrous cap, where they can exert 
their cap-erosive functions.
Our experiments thus underpin the importance of Hck/
Fgr not only in migration, but also in macrophage profibrotic 
differentiation. Analysis of microarray data sets and our gene 
expression studies point to divergent regulation of Hck and 
Fgr expression in response to macrophage classical and alter-
native polarization, supportive of a role for these kinases in the 
spectrum of macrophage immune differentiation. However, 
we did not observe consistent Hck/Fgr deficiency–associated 
shifts in macrophage polarization marker expression, but 
Hck/Fgr-deficient macrophage displayed functional changes 
relevant to plaque stability, with inhibited SMC extracellular 
matrix protein deposition and reduced efferocytosis capacity 
as the most prominent features.
In conclusion, Hck and Fgr deficiency is associated with a 
reduced recruitment of myeloid cells to the plaque, despite the 
observed skewing of monocytes toward the proinflammatory 
Ly-6Chi monocytes. However, the beneficial effects of reduced 
leukocyte influx are counteracted by the focal retention of 
extravasated monocytes in the fibrous cap, promoting its ero-
sion and plaque vulnerability. The apparent profibrotic func-
tion of Hck/Fgr raises a note of caution against the use of Src 
kinase inhibitors for the treatment of atherosclerosis, where 
reduced macrophage accumulation and fibrous cap integrity 
are desired to attain a stable plaque profile. However, their 
novel application as antifibrotic therapy in systemic sclero-
sis32,33 and our results support their potential to treat fibroblas-
tic vasculopathies such as restenosis and disorders where the 
simultaneous reduction of fibrosis and macrophage accumula-
tion are desired.
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CLINICAL PERSPECTIvE
Atherosclerosis, a major underlying cause for cardiovascular disorders is a chronic lipid-driven inflammatory disease that 
is impacted by many risk factors: hypertension, dyslipidemia, type 2 diabetes mellitus, etc. Current drug therapy appears to 
reduce the risk of future cardiovascular events in 30% of patients, urging for new complementary medication to also reduce 
risk in poorly responding patients. It is in this context that inflammation has been embraced as a potential target for interven-
tion. In particular, the accumulation and activity in atherosclerotic plaque of potentially deleterious leukocyte subsets have 
so far been investigated for their effectiveness to quench plaque inflammation and improve its stability, both in preclinical 
and, albeit with little success, in clinical studies. In this study, we have interrogated the therapeutic potential of inhibition 
of the mobility of plaque macrophages, the abundant presence of which is viewed as a hallmark of the vulnerable plaque. 
We are the first to show that hyperlipidemic mice with blunted expression of 2 drugable regulators of phagocyte mobility 
(the kinases Hck and Fgr) have smaller plaques, which paradoxically display clear features of increased vulnerability, such 
as thinned fibrous caps. We were able to demonstrate that this may be caused by trapping newly invaded phagocytes in the 
fibrous cap region, creating a lytic milieu that will affect focal erosion. Our findings thus raise a note of caution regarding 
the therapeutic value of Hck and Fgr as key targets for intervention in plaque inflammation.
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